Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takamitsu Inoue

Showing results (31-40 of 185) with videos related to

Pageof 19
Sort By:
Steroids|May 27, 2008
Influence of CYP3A5, ABCB1 and NR1I2 polymorphisms on prednisolone pharmacokinetics in renal transplant recipientsMasatomo Miura, Shigeru Satoh, Kazuyuki Inoue, et al.
Frontiers in Pediatrics|November 21, 2022
Are we ready for building transition programs for heart transplant recipients in Japan? - Knowing the unique background is the first step for discussionTomoko S Kato, Harumi Gomi, Yoshiyasu Aizawa, et al.
Pharmacological Reports : PR|March 28, 2020
Changes in PCSK9 and LDL cholesterol concentrations by everolimus treatment and their effects on polymorphisms in PCSK9 and mTORC1Shiori Sato, Yumiko Akamine, Hideaki Kagaya, et al.
Hinyokika Kiyo. Acta Urologica Japonica|October 16, 2007
Possible survival benefit of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin combination therapy (HD-MVAC) over conventional MVAC in metastatic urothelial carcinoma patientsTakamitsu Inoue, Takashi Obara, Mitsuru Saito, et al.
Clinical and Experimental Nephrology|March 9, 2017
Impact of the CYP3A5 genotype on the distributions of dose-adjusted trough concentrations and incidence of rejection in Japanese renal transplant recipients receiving different tacrolimus formulationsTakenori Niioka, Hideaki Kagaya, Mitsuru Saito, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 24, 2006
External iliac pseudoaneurysm ruptured into non-functioning intrarenal allograft abscessed massTakamitsu Inoue, Shigeru Satoh, Kazuyuki Numakura, et al.
Oncology Reports|March 8, 2007
Low concentrations of the histone deacetylase inhibitor, depsipeptide, enhance the effects of gemcitabine and docetaxel in hormone refractory prostate cancer cellsMasatoshi Kanzaki, Hideaki Kakinuma, Teruaki Kumazawa, et al.
BMC Urology|November 13, 2008
Characterization of prostate cancer detected at repeat biopsyTakeshi Yuasa, Norihiko Tsuchiya, Teruaki Kumazawa, et al.
The Prostate|April 20, 2012
A high-fat diet enhances proliferation of prostate cancer cells and activates MCP-1/CCR2 signalingMingguo Huang, Shintaro Narita, Kazuyuki Numakura, et al.
Cancer Letters|May 7, 2005
CYP3A5 gene polymorphism and risk of prostate cancer in a Japanese populationLi Zhenhua, Norihiko Tsuchiya, Shintaro Narita, et al.
Pageof 19

Showing results (31-40 of 185) with videos related to

Sort By:
Pageof 19
Steroids|May 27, 2008
Influence of CYP3A5, ABCB1 and NR1I2 polymorphisms on prednisolone pharmacokinetics in renal transplant recipientsMasatomo Miura, Shigeru Satoh, Kazuyuki Inoue, et al.
Frontiers in Pediatrics|November 21, 2022
Are we ready for building transition programs for heart transplant recipients in Japan? - Knowing the unique background is the first step for discussionTomoko S Kato, Harumi Gomi, Yoshiyasu Aizawa, et al.
Pharmacological Reports : PR|March 28, 2020
Changes in PCSK9 and LDL cholesterol concentrations by everolimus treatment and their effects on polymorphisms in PCSK9 and mTORC1Shiori Sato, Yumiko Akamine, Hideaki Kagaya, et al.
Hinyokika Kiyo. Acta Urologica Japonica|October 16, 2007
Possible survival benefit of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin combination therapy (HD-MVAC) over conventional MVAC in metastatic urothelial carcinoma patientsTakamitsu Inoue, Takashi Obara, Mitsuru Saito, et al.
Clinical and Experimental Nephrology|March 9, 2017
Impact of the CYP3A5 genotype on the distributions of dose-adjusted trough concentrations and incidence of rejection in Japanese renal transplant recipients receiving different tacrolimus formulationsTakenori Niioka, Hideaki Kagaya, Mitsuru Saito, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 24, 2006
External iliac pseudoaneurysm ruptured into non-functioning intrarenal allograft abscessed massTakamitsu Inoue, Shigeru Satoh, Kazuyuki Numakura, et al.
Oncology Reports|March 8, 2007
Low concentrations of the histone deacetylase inhibitor, depsipeptide, enhance the effects of gemcitabine and docetaxel in hormone refractory prostate cancer cellsMasatoshi Kanzaki, Hideaki Kakinuma, Teruaki Kumazawa, et al.
BMC Urology|November 13, 2008
Characterization of prostate cancer detected at repeat biopsyTakeshi Yuasa, Norihiko Tsuchiya, Teruaki Kumazawa, et al.
The Prostate|April 20, 2012
A high-fat diet enhances proliferation of prostate cancer cells and activates MCP-1/CCR2 signalingMingguo Huang, Shintaro Narita, Kazuyuki Numakura, et al.
Cancer Letters|May 7, 2005
CYP3A5 gene polymorphism and risk of prostate cancer in a Japanese populationLi Zhenhua, Norihiko Tsuchiya, Shintaro Narita, et al.
Pageof 19